Abstract
Objective:
To determine whether phenobarbital (PB) given before therapeutic hypothermia to infants with hypoxic-ischemic encephalopathy (HIE) augments the neuroprotective efficacy of hypothermia.
Study Design:
Records of 68 asphyxiated infants of ⩾36 weeks’ gestation, who received hypothermia for moderate or severe HIE were reviewed. Some of these infants received PB prophylactically or for clinical seizures. All surviving infants had later brain magnetic resonance imaging (MRI). The composite primary outcome of neonatal death related to HIE with worsening multiorgan dysfunction despite maximal treatment, and the presence of post-hypothermia brain MRI abnormalities consistent with hypoxic-ischemic brain injury, were compared between the infants who received PB before initiation of hypothermia (PB group, n=36) and the infants who did not receive PB before or during hypothermia (No PB group, n=32). Forward logistic regression analysis determined which of the pre-hypothermia clinical and laboratory variables predict the primary outcome.
Result:
The two groups were similar for severity of asphyxia as assessed by Apgar scores, initial blood pH and base deficit, early neurologic examination, and presence of an intrapartum sentinel event. The composite primary outcome was more frequent in infants from the PB group (PB 78% versus No PB 44%, P=0.006, odds ratio 4.5, 95% confidence interval 1.6 to 12.8). Multivariate analysis identified only the PB receipt before initiation of hypothermia (P=0.002, odds ratio 9.5, 95% confidence interval 2.3 to 39.5), and placental abruption to be independently associated with a worse primary outcome.
Conclusion:
PB treatment before cooling did not improve the composite outcome of neonatal death or the presence of an abnormal post-hypothermia brain MRI, but the long-term outcomes have not yet been evaluated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gunn AJ, Thoresen M . Hypothermic neuroprotection. Neuro Rx 2006; 3 (2): 154–169.
Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363.
Nilsson L . The influence of barbiturate anaethesia upon the energy state and upon acid-base parameters of the brain in arterial hypotension and in asphyxia. Acta Neurologica Scandinavica 1971; 47: 233–253.
Demopoulos HG, Flamm ES, Seligman MC . Antioxidant effects of barbiturates in model membranes undergoing free radical damage. Acta Neurologica Scandinavica 1977; 56 (Suppl 64): 152–153.
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365: 663–670.
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574–1584.
Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen F et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol 1998; 19: 143–149.
Barkovich AJ, Westmark K, Partridge C, Sola A, Ferriero DM . Perinatal asphyxia: MR findings in the first 10 days. AJNR Am J Neuroradiol 1995; 16: 427–438.
Ambalavanan N, Carlo WA, Shankaran S, Bann CM, Emrich SL, Higgins RD et al. National Institute of Child Health and Human Development Neonatal Research Network. Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy. Pediatrics 2006; 118 (5): 2084–2093.
Miller SP, Weiss J, Barnwell A, Ferriero DM, Latal-Hajnal B, Ferrer-Rogers A et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002; 58 (4): 542–548.
Glass HC, Glidden D, Jeremy RJ, Barkovich AJ, Ferriero DM, Miller SP . Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009; 155 (3): 318–323.
Singh D, Kumar P, Majumdar S, Narang A . Effect of phenobarbital on free radicals in neonates with hypoxic ischemic encephalopathy-a randomized controlled trial. J Perinatal Med 2004; 32: 278–281.
Hall RT, Hall FK, Daily DK . High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998; 132: 345–348.
Goldberg RN, Moscoso P, Bauer CR, Bloom FL, Curless RG, Burke B et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr 1986; 109: 851–856.
Evans DJ, Levene MI, Tsakmakis M . Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev 2007; (3) Art. no.: CD001240.
Meyn Jr DF, Ness J, Ambalavanan N, Carlo WA . Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy. J Pediatr 2010; 157 (2): 334–336.
Diaz J, Schain RJ . Phenobarbital: effects of long-term administration on behavior and brain of artificially reared rats. Science 1978; 199 (4324): 90–91.
Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002; 99 (23): 15089–15094.
Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C . Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006; 63 (4): 399–413.
Rutherford M, Ramenghi LA, Edwards AD, Brocklehurst P, Halliday H, Levene M et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial. Lancet Neurol 2010; 9: 39–45.
Barks JD, Liu YQ, Shangguan Y, Silverstein FS . Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010; 67 (5): 532–537.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sarkar, S., Barks, J., Bapuraj, J. et al. Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?. J Perinatol 32, 15–20 (2012). https://doi.org/10.1038/jp.2011.41
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2011.41
Keywords
This article is cited by
-
Interventions for the Management of Pain and Sedation in Newborns Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: A Systematic Review
Pediatric Drugs (2023)
-
Adjunctive Neuroprotective Therapies for Treatment of Hypoxic-Ischemic Encephalopathy (HIE)
Current Pediatrics Reports (2020)
-
Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs
BMC Pediatrics (2019)
-
Predicting the need for home gavage or g-tube feeds in asphyxiated neonates treated with therapeutic hypothermia
Journal of Perinatology (2018)
-
The effects of adding prophylactic phenobarbital to therapeutic hypothermia in the term-equivalent hypoxic–ischemic rat
Pediatric Research (2018)